异甘草酸镁对原发性肝癌肝动脉化疗栓塞术后肝脏的保护作用研究

被引:7
作者
李红玲
李世波
张浙恩
机构
[1] 温州医科大学附属舟山医院感染性疾病科
关键词
异甘草酸镁; 原发性肝癌; 肝动脉化疗栓塞术; 肝功能;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
目的探讨异甘草酸镁对原发性肝癌肝动脉化疗栓塞术后肝脏的保护作用。方法选择原发性肝癌肝动脉化疗栓塞术患者68例作为研究对象, 将其分为异甘草酸镁组和对照组, 所有患者均在术前7 d到术后3 d常规给予保肝药物治疗, 异甘草酸镁组在保肝治疗的基础上给予异甘草酸镁治疗, 检测并比较两组肝癌患者手术前后肝谷丙转氨酶、谷草转氨酶、总胆红素、总蛋白、白蛋白和胆碱酯酶水平。结果对照组术后3 d的谷丙转氨酶、谷草转氨酶[(60.2±25.8)IU/L、(71.5±29.6)IU/L]均较术前升高[(34.7±18.6)IU/L、(49.5±20.4)IU/L](t=7.264、5.974, 均P<0.05), 异甘草酸镁组术后3 d的肝损伤指标谷丙转氨酶、谷草转氨酶与术前差异无统计学意义(P>0.05);异甘草酸镁组术前谷丙转氨酶、谷草转氨酶和总胆红素与对照组差异无统计学意义(P>0.05), 异甘草酸镁组术后3 d谷丙转氨酶、谷草转氨酶[(44.8±22.8)IU/L、(57.3±24.8)IU/L]均明显低于对照组[(60.2±25.8)IU/L、(71.5±29.6)IU/L](t=6.385、7.358, 均P<0.05)。异甘草酸镁组和对照组术后3 d的白蛋白和胆碱酯酶[(28.4±4.7)g/L、(8.0±4.8)kU/L比(29.3±3.5)g/L、(6.9±4.3)kU/L]均较术前降低[(34.2±4.3)g/L、(9.3±5.4)kU/L比(33.7±3.9)g/L、(9.0±5.8)kU/L](t=11.834、6.247、10.276、8.743, 均P<0.05), 异甘草酸镁组术前白蛋白和胆碱酯酶与对照组差异无统计学意义(P>0.05), 异甘草酸镁组术后3 d白蛋白和胆碱酯酶[(28.4±4.7)g/L、(8.0±4.8)kU/L]均明显高于对照组[(29.3±3.5)g/L、(6.9±4.3)kU/L](t=8.436、6.947, 均P<0.05)。异甘草酸镁组不良反应发生率(上腹痛发生率为35.3%, 发热发生率为29.4%, 恶心呕吐发生率为52.9%)低于对照组(上腹痛发生率55.9%, 发热发生率88.2%, 恶心呕吐发生率为76.5%)(χ2=7.246、6.472、6.274, 均P<0.05)。结论肝动脉化疗栓塞术对肝癌患者的肝功能有一定的损伤, 异甘草酸镁可以减轻肝脏损害, 提高肝脏合成功能, 对肝脏有一定的保护作用。
引用
收藏
相关论文
共 9 条
[1]
Long-term Survivors After Liver Resection for Ovarian Cancer Liver Metastases [J].
Bacalbasa, Nicolae ;
Balescu, Irina ;
Dima, Simona ;
Popescu, Irinel .
ANTICANCER RESEARCH, 2015, 35 (12) :6919-6923
[2]
Preoperative Nutritional Risk Index to predict postoperative survival time in primary liver cancer patients [J].
Bo, Yacong ;
Yao, Mingjie ;
Zhang, Ling ;
Sapa, Wolde Bekalo ;
Lu, Weiquan ;
Lu, Quanjun .
ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2015, 24 (04) :591-597
[3]
Incidence and therapeutic frequency of extrahepatic collateral arteries in transcatheter arterial chemoembolization of hepatocellular carcinoma: Experience from 182 patients with survival time more than 3 years [J].
Li, Qiang ;
Ao, Guo-Kun ;
Duan, Feng ;
Wang, Zhi-Jun ;
Yan, Jie-Yu ;
Wang, Mao-Qiang .
EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (12) :2555-2563
[4]
Recurrence of liver metastases from colorectal cancer and repeat liver resection [J].
Navarro Freirei, Francisco ;
Navarro Sanchez, Patricia ;
Miron Pozo, Benito ;
Teresa Delgado Urena, Maria ;
Antonio Jimenez Rios, Jose ;
Antonio Garcia Lopez, Pedro ;
Ignacio Arcelus Martinez, Juan .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (12) :732-739
[5]
Preoperative portal vein embolization in liver cancer: indications, techniques and outcomes [J].
Loffroy, Romaric ;
Favelier, Sylvain ;
Chevallier, Olivier ;
Estivalet, Louis ;
Genson, Pierre-Yves ;
Pottecher, Pierre ;
Gehin, Sophie ;
Krause, Denis ;
Cercueil, Jean-Pierre .
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2015, 5 (05) :730-739
[6]
Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience [J].
Minami, Yasunori ;
Minami, Tomohiro ;
Chishina, Hirokazu ;
Arizumi, Tadaaki ;
Takita, Masahiro ;
Kitai, Satoshi ;
Yada, Norihisa ;
Hagiwara, Satoru ;
Tsurusaki, Masakatsu ;
Yagyu, Yukinobu ;
Ueshima, Kazuomi ;
Nishida, Naoshi ;
Murakami, Takamichi ;
Kudo, Masatoshi .
ONCOLOGY, 2015, 89 :27-32
[7]
Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway [J].
Xie, Chunfeng ;
Li, Xiaoting ;
Wu, Jieshu ;
Liang, Zhaofeng ;
Deng, Feifei ;
Xie, Wei ;
Zhu, Mingming ;
Zhu, Jianyun ;
Zhu, Weiwei ;
Geng, Shanshan ;
Zhong, Caiyun .
INFLAMMATION, 2015, 38 (04) :1639-1648
[8]
Transcatheter arterial chemoembolization as an examination method forhepatocellular carcinoma undetected by B‑mode ultrasound; computed tomographyand digital subtratcion angiography: A case report.[J].Zongquan Xu;Chen Yu;Shufang Wang;Guohui Xu.Oncology Letters.2015, 3
[9]
Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study [J].
Chen, Kai Jie ;
Chen, Wan Yi ;
Chen, Xia ;
Jia, Yi Ming ;
Peng, Gui Qin ;
Chen, Li .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2014, 39 (01) :25-31